Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06241768 · ClinicalTrials.gov registry record · NA
Feasibility of a Colorectal Cancer Screening Web App in Primary Care Patients
A NA study, sponsored by Digital Health Navigation Solutions.
- Completed
- Registry status
- NA
- Development phase
- 921
- Enrollment target
NCT06241768: Completed NA study, sponsored by Digital Health Navigation Solutions.
NCT06241768 is a NA study that has completed, run by Digital Health Navigation Solutions. The registered enrollment target is 921 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06241768, a NA study, has completed, sponsored by Digital Health Navigation Solutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 921 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test the feasibility of a web app about colorectal cancer screening in patients with an upcoming primary care appointment. The main questions it aims to answer are: * Among patients who use the web app, what proportion will request a colorectal cancer screening test via the program? * How many patients will respond to a text message intervention to use the web app? Participants will receive a text message informing them of the value of colorectal cancer screening, and inviting them to click a hyperlink to learn more. The hyperlink will take participants to the web app. The web app: 1) asks questions and use algorithms to determine if routine colorectal cancer screening is needed, and 2) if screening is indicated, shows a brief educational video about colorectal cancer screening and allows participants to request a screening test via the program. Researchers will compare four different versions of the text message invitation to see if some messages result in higher program completion rates than others.
Primary Outcome
Number (and proportion) of participants who are confirmed eligible for CRC screening and request a CRC screening test within the mPATH-CRC Web App
Interventions
- OTHER mPATH-CRC Web app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 921 participants |
| Start Date | 2024-02-05 |
| Est. Completion | 2024-03-26 |
| Phase | NA |
What the finished NCT06241768 record still lists
NCT06241768 is an interventional study that assigns participants to a tested intervention. The registered 921 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% lower).
The record links to 0 conditions, and to 1 intervention - of which mPATH-CRC Web app is the first listed.
NCT06241768 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06241768 about?
NCT06241768 is a clinical study titled "Feasibility of a Colorectal Cancer Screening Web App in Primary Care Patients". The goal of this clinical trial is to test the feasibility of a web app about colorectal cancer screening in patients with an upcoming primary care appointment. The main questions it aims to answer are: * Among patients who use the web app, what proportion will request a colorectal cancer screening...
What is the current status of trial NCT06241768?
This trial is currently completed. It is a NA study. The enrollment target is 921 participants. The study started on 2024-02-05. Estimated completion is 2024-03-26.
What interventions are being tested in trial NCT06241768?
The interventions under investigation include: mPATH-CRC Web app (OTHER).
Who is sponsoring clinical trial NCT06241768?
This trial is sponsored by Digital Health Navigation Solutions, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06241768's enrollment target sits among peer trials
921 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07151001 · 922 participants
Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic Retinopathy
- NCT04589845 · 920 participants · Phase 2
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
- NCT06109870 · 920 participants · NA
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
- NCT06957366 · 920 participants · NA
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI